| CAS ID: | 908253-63-4 |
| Molecular Formula: | C21H22FN3O5 |
| Molecular Weight: | 415.4 g/mol |
| Monoisotopic Mass: | 415.1543 g/mol |
| Class: | Small Molecule |
| Natural Product: | No |
| Other Names: | NIVOCASAN | GS-9450 | LB84451 |
| Analysis: | Drug repositioning mechanism analysis |
| InChI: | InChI=1S/C21H22FN3O5/c1-12(2)20(19(27)24-16-9-17(26)29-21(16,28)11-22)10-15(25-30-20)18-14-6-4-3-5-13(14)7-8-23-18/h3-8,12,16,28H,9-11H2,1-2H3,(H,24,27)/t16-,20+,21+/m0/s1 | See All |
| InChI Key: | VYFGDLGHHBUDTQ-ZLGUVYLKSA-N | |
| Smiles: | CC(C)[C@]1(CC(=NO1)c2nccc3ccccc23)C(=O)N[C@H]4CC(=O)O[C@]4(O)CF | See All |
| Molfile: | Download |
Trial Record 1
| ClinicalTrial ID | NCT00725803 | Disease | Liver fibrosis |
| Phase | Phase 2 | Status | Completed |
| First Received | July 31, 2008 | Last Verified | June 19, 2014 |
| Sponsor | Gilead Sciences | ||
| PubChem: | 11633038 |
| ChEMBL: | CHEMBL2105721 |